Core Points - The report details a reduction in shareholding by Best Idea International Limited in Shanghai Mengke Pharmaceutical Co., Ltd, decreasing its stake from 10.49% to 8.91% [1][5][7] - The shareholding change was executed without the need for approval from relevant authorities and does not impose any additional conditions [2][5] - Best Idea International Limited's decision to reduce its stake is driven by funding needs [5][6] Group 1: Shareholding Details - Before the change, Best Idea held 68,752,718 shares, representing 10.49% of the total shares [5][7] - After the change, Best Idea holds 58,439,004 shares, which is 8.91% of the total shares [5][7] - The reduction in shareholding amounts to 10,313,714 shares, equating to a decrease of 1.57% in ownership [5][7] Group 2: Company Information - Shanghai Mengke Pharmaceutical Co., Ltd is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board under the stock code 688373 [1][4] - Best Idea International Limited, the disclosing party, is based in Hong Kong and was established on July 22, 2010 [4][5] - The report confirms that Best Idea does not hold significant stakes in any other listed companies [5]
盟科药业: 上海盟科药业股份有限公司简式权益变动报告书(Best Idea International Limited)